secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRC HEALTH (NRC)
CIK:        0000070487
Form:       8-K
Filed at:   2026-04-28T23:59:59+00:00
Accession:  0001437749-26-013641
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRC Health Q1 revenue up 4% to $34.8M; TRCV record $152.1M (+13% YoY)
---------------------------------------------------------------------

- GAAP net income $3.2M ($0.14 diluted EPS); adjusted net income $4.6M ($0.21 adjusted diluted EPS).
- Adjusted EBITDA $9.4M (27% of revenue); cash flow from operations $7.2M up 8% YoY.
- Total Recurring Contract Value (TRCV) $152.1M, up 13% YoY, sixth consecutive quarterly increase.
- Company signed the largest deal in its 45-year history; new sales and retention reached multi-year highs.
- Free cash flow $5.4M (15% of revenue); revenue $34.8M, first YoY growth since 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/70487/000143774926013641/0001437749-26-013641-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/70487/000143774926013641/nrc20260424_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-013641

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer